aluates Reports

$ 0.0

Automative

Respiratory Syncytial Virus (RSV) Diagnostics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Published Date: November 2024

Report Code: QYRE-Auto-6S6143

Global Respiratory Syncytial Virus RSV Diagnostics Market Insights and Forecast to 2028

BUY CHAPTERS

Respiratory Syncytial Virus (RSV) Diagnostics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-6S6143

Report

November 2024

Pages:91

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Roche

Astrazeneca plc

Merck

AbbVie

Bausch Health

GlaxoSmithKline PLC

ReViral

Gilead Sciences

Teva Pharmaceutical

Respiratory Syncytial Virus (RSV) Diagnostics - Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Respiratory Syncytial Virus (RSV) Diagnostics - Market

The global market for Respiratory Syncytial Virus (RSV) Diagnostics was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Respiratory Syncytial Virus (RSV) Diagnostics, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Respiratory Syncytial Virus (RSV) Diagnostics by region & country, by Type, and by Application.

The Respiratory Syncytial Virus (RSV) Diagnostics market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Respiratory Syncytial Virus (RSV) Diagnostics.

Market Segmentation

Scope of Respiratory Syncytial Virus (RSV) Diagnostics - Market Report

Report Metric	Details
Report Name	Respiratory Syncytial Virus (RSV) Diagnostics - Market
CAGR	5%
Segment by Type:	Molecular Diagnosis Rapid Antigen Testing Other
Segment by Application	Hospital Clinic Laborary Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Roche, AstraZeneca, Merck, AbbVie, Bausch Health, GlaxoSmithKline, ReViral, Gilead Sciences, Teva Pharmaceutical
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Respiratory Syncytial Virus (RSV) Diagnostics manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Respiratory Syncytial Virus (RSV) Diagnostics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Respiratory Syncytial Virus (RSV) Diagnostics in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

Who are the main players in the Respiratory Syncytial Virus (RSV) Diagnostics - Market report?

Ans: The main players in the Respiratory Syncytial Virus (RSV) Diagnostics - Market are Roche, AstraZeneca, Merck, AbbVie, Bausch Health, GlaxoSmithKline, ReViral, Gilead Sciences, Teva Pharmaceutical

What are the Application segmentation covered in the Respiratory Syncytial Virus (RSV) Diagnostics - Market report?

Ans: The Applications covered in the Respiratory Syncytial Virus (RSV) Diagnostics - Market report are Hospital, Clinic, Laborary, Other

What are the Type segmentation covered in the Respiratory Syncytial Virus (RSV) Diagnostics - Market report?

Ans: The Types covered in the Respiratory Syncytial Virus (RSV) Diagnostics - Market report are Molecular Diagnosis, Rapid Antigen Testing, Other

Recommended Reports

Respiratory Virus Diagnostics

Infectious Disease Testing

Respiratory Therapeutics

1 Market Overview

1.1 Respiratory Syncytial Virus (RSV) Diagnostics Product Introduction

1.2 Global Respiratory Syncytial Virus (RSV) Diagnostics Market Size Forecast

1.3 Respiratory Syncytial Virus (RSV) Diagnostics Market Trends & Drivers

1.3.1 Respiratory Syncytial Virus (RSV) Diagnostics Industry Trends

1.3.2 Respiratory Syncytial Virus (RSV) Diagnostics Market Drivers & Opportunity

1.3.3 Respiratory Syncytial Virus (RSV) Diagnostics Market Challenges

1.3.4 Respiratory Syncytial Virus (RSV) Diagnostics Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Respiratory Syncytial Virus (RSV) Diagnostics Players Revenue Ranking (2023)

2.2 Global Respiratory Syncytial Virus (RSV) Diagnostics Revenue by Company (2019-2024)

2.3 Key Companies Respiratory Syncytial Virus (RSV) Diagnostics Manufacturing Base Distribution and Headquarters

2.4 Key Companies Respiratory Syncytial Virus (RSV) Diagnostics Product Offered

2.5 Key Companies Time to Begin Mass Production of Respiratory Syncytial Virus (RSV) Diagnostics

2.6 Respiratory Syncytial Virus (RSV) Diagnostics Market Competitive Analysis

2.6.1 Respiratory Syncytial Virus (RSV) Diagnostics Market Concentration Rate (2019-2024)

2.6.2 Global 5 and 10 Largest Companies by Respiratory Syncytial Virus (RSV) Diagnostics Revenue in 2023

2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Respiratory Syncytial Virus (RSV) Diagnostics as of 2023)

2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Molecular Diagnosis

3.1.2 Rapid Antigen Testing

3.1.3 Other

3.2 Global Respiratory Syncytial Virus (RSV) Diagnostics Sales Value by Type

3.2.1 Global Respiratory Syncytial Virus (RSV) Diagnostics Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Respiratory Syncytial Virus (RSV) Diagnostics Sales Value, by Type (2019-2030)

3.2.3 Global Respiratory Syncytial Virus (RSV) Diagnostics Sales Value, by Type (%) (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Hospital

4.1.2 Clinic

4.1.3 Laborary

4.1.4 Other

4.2 Global Respiratory Syncytial Virus (RSV) Diagnostics Sales Value by Application

4.2.1 Global Respiratory Syncytial Virus (RSV) Diagnostics Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Respiratory Syncytial Virus (RSV) Diagnostics Sales Value, by Application (2019-2030)

4.2.3 Global Respiratory Syncytial Virus (RSV) Diagnostics Sales Value, by Application (%) (2019-2030)

5 Segmentation by Region

5.1 Global Respiratory Syncytial Virus (RSV) Diagnostics Sales Value by Region

5.1.1 Global Respiratory Syncytial Virus (RSV) Diagnostics Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Respiratory Syncytial Virus (RSV) Diagnostics Sales Value by Region (2019-2024)

5.1.3 Global Respiratory Syncytial Virus (RSV) Diagnostics Sales Value by Region (2025-2030)

5.1.4 Global Respiratory Syncytial Virus (RSV) Diagnostics Sales Value by Region (%), (2019-2030)

5.2 North America

5.2.1 North America Respiratory Syncytial Virus (RSV) Diagnostics Sales Value, 2019-2030

5.2.2 North America Respiratory Syncytial Virus (RSV) Diagnostics Sales Value by Country (%), 2023 VS 2030

5.3 Europe

5.3.1 Europe Respiratory Syncytial Virus (RSV) Diagnostics Sales Value, 2019-2030

5.3.2 Europe Respiratory Syncytial Virus (RSV) Diagnostics Sales Value by Country (%), 2023 VS 2030

5.4 Asia Pacific

5.4.1 Asia Pacific Respiratory Syncytial Virus (RSV) Diagnostics Sales Value, 2019-2030

5.4.2 Asia Pacific Respiratory Syncytial Virus (RSV) Diagnostics Sales Value by Country (%), 2023 VS 2030

5.5 South America

5.5.1 South America Respiratory Syncytial Virus (RSV) Diagnostics Sales Value, 2019-2030

5.5.2 South America Respiratory Syncytial Virus (RSV) Diagnostics Sales Value by Country (%), 2023 VS 2030

5.6 Middle East & Africa

5.6.1 Middle East & Africa Respiratory Syncytial Virus (RSV) Diagnostics Sales Value, 2019-2030

5.6.2 Middle East & Africa Respiratory Syncytial Virus (RSV) Diagnostics Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Respiratory Syncytial Virus (RSV) Diagnostics Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Respiratory Syncytial Virus (RSV) Diagnostics Sales Value

6.3 United States

6.3.1 United States Respiratory Syncytial Virus (RSV) Diagnostics Sales Value, 2019-2030

6.3.2 United States Respiratory Syncytial Virus (RSV) Diagnostics Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Respiratory Syncytial Virus (RSV) Diagnostics Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Respiratory Syncytial Virus (RSV) Diagnostics Sales Value, 2019-2030

6.4.2 Europe Respiratory Syncytial Virus (RSV) Diagnostics Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Respiratory Syncytial Virus (RSV) Diagnostics Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Respiratory Syncytial Virus (RSV) Diagnostics Sales Value, 2019-2030

6.5.2 China Respiratory Syncytial Virus (RSV) Diagnostics Sales Value by Type (%), 2023 VS 2030

6.5.3 China Respiratory Syncytial Virus (RSV) Diagnostics Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Respiratory Syncytial Virus (RSV) Diagnostics Sales Value, 2019-2030

6.6.2 Japan Respiratory Syncytial Virus (RSV) Diagnostics Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Respiratory Syncytial Virus (RSV) Diagnostics Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Respiratory Syncytial Virus (RSV) Diagnostics Sales Value, 2019-2030

6.7.2 South Korea Respiratory Syncytial Virus (RSV) Diagnostics Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Respiratory Syncytial Virus (RSV) Diagnostics Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Respiratory Syncytial Virus (RSV) Diagnostics Sales Value, 2019-2030

6.8.2 Southeast Asia Respiratory Syncytial Virus (RSV) Diagnostics Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Respiratory Syncytial Virus (RSV) Diagnostics Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Respiratory Syncytial Virus (RSV) Diagnostics Sales Value, 2019-2030

6.9.2 India Respiratory Syncytial Virus (RSV) Diagnostics Sales Value by Type (%), 2023 VS 2030

6.9.3 India Respiratory Syncytial Virus (RSV) Diagnostics Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Roche

7.1.1 Roche Profile

7.1.2 Roche Main Business

7.1.3 Roche Respiratory Syncytial Virus (RSV) Diagnostics Products, Services and Solutions

7.1.4 Roche Respiratory Syncytial Virus (RSV) Diagnostics Revenue (US$ Million) & (2019-2024)

7.1.5 Roche Recent Developments

7.2 AstraZeneca

7.2.1 AstraZeneca Profile

7.2.2 AstraZeneca Main Business

7.2.3 AstraZeneca Respiratory Syncytial Virus (RSV) Diagnostics Products, Services and Solutions

7.2.4 AstraZeneca Respiratory Syncytial Virus (RSV) Diagnostics Revenue (US$ Million) & (2019-2024)

7.2.5 AstraZeneca Recent Developments

7.3 Merck

7.3.1 Merck Profile

7.3.2 Merck Main Business

7.3.3 Merck Respiratory Syncytial Virus (RSV) Diagnostics Products, Services and Solutions

7.3.4 Merck Respiratory Syncytial Virus (RSV) Diagnostics Revenue (US$ Million) & (2019-2024)

7.3.5 AbbVie Recent Developments

7.4 AbbVie

7.4.1 AbbVie Profile

7.4.2 AbbVie Main Business

7.4.3 AbbVie Respiratory Syncytial Virus (RSV) Diagnostics Products, Services and Solutions

7.4.4 AbbVie Respiratory Syncytial Virus (RSV) Diagnostics Revenue (US$ Million) & (2019-2024)

7.4.5 AbbVie Recent Developments

7.5 Bausch Health

7.5.1 Bausch Health Profile

7.5.2 Bausch Health Main Business

7.5.3 Bausch Health Respiratory Syncytial Virus (RSV) Diagnostics Products, Services and Solutions

7.5.4 Bausch Health Respiratory Syncytial Virus (RSV) Diagnostics Revenue (US$ Million) & (2019-2024)

7.5.5 Bausch Health Recent Developments

7.6 GlaxoSmithKline

7.6.1 GlaxoSmithKline Profile

7.6.2 GlaxoSmithKline Main Business

7.6.3 GlaxoSmithKline Respiratory Syncytial Virus (RSV) Diagnostics Products, Services and Solutions

7.6.4 GlaxoSmithKline Respiratory Syncytial Virus (RSV) Diagnostics Revenue (US$ Million) & (2019-2024)

7.6.5 GlaxoSmithKline Recent Developments

7.7 ReViral

7.7.1 ReViral Profile

7.7.2 ReViral Main Business

7.7.3 ReViral Respiratory Syncytial Virus (RSV) Diagnostics Products, Services and Solutions

7.7.4 ReViral Respiratory Syncytial Virus (RSV) Diagnostics Revenue (US$ Million) & (2019-2024)

7.7.5 ReViral Recent Developments

7.8 Gilead Sciences

7.8.1 Gilead Sciences Profile

7.8.2 Gilead Sciences Main Business

7.8.3 Gilead Sciences Respiratory Syncytial Virus (RSV) Diagnostics Products, Services and Solutions

7.8.4 Gilead Sciences Respiratory Syncytial Virus (RSV) Diagnostics Revenue (US$ Million) & (2019-2024)

7.8.5 Gilead Sciences Recent Developments

7.9 Teva Pharmaceutical

7.9.1 Teva Pharmaceutical Profile

7.9.2 Teva Pharmaceutical Main Business

7.9.3 Teva Pharmaceutical Respiratory Syncytial Virus (RSV) Diagnostics Products, Services and Solutions

7.9.4 Teva Pharmaceutical Respiratory Syncytial Virus (RSV) Diagnostics Revenue (US$ Million) & (2019-2024)

7.9.5 Teva Pharmaceutical Recent Developments

8 Industry Chain Analysis

8.1 Respiratory Syncytial Virus (RSV) Diagnostics Industrial Chain

8.2 Respiratory Syncytial Virus (RSV) Diagnostics Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Respiratory Syncytial Virus (RSV) Diagnostics Sales Model

8.5.2 Sales Channel

8.5.3 Respiratory Syncytial Virus (RSV) Diagnostics Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

Roche

Astrazeneca plc

Merck

AbbVie

Bausch Health

GlaxoSmithKline PLC

ReViral

Gilead Sciences

Teva Pharmaceutical

List of Tables

Table 1. Respiratory Syncytial Virus (RSV) Diagnostics Market Trends

Table 2. Respiratory Syncytial Virus (RSV) Diagnostics Market Drivers & Opportunity

Table 3. Respiratory Syncytial Virus (RSV) Diagnostics Market Challenges

Table 4. Respiratory Syncytial Virus (RSV) Diagnostics Market Restraints

Table 5. Global Respiratory Syncytial Virus (RSV) Diagnostics Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Respiratory Syncytial Virus (RSV) Diagnostics Revenue Market Share by Company (2019-2024)

Table 7. Key Companies Respiratory Syncytial Virus (RSV) Diagnostics Manufacturing Base Distribution and Headquarters

Table 8. Key Companies Respiratory Syncytial Virus (RSV) Diagnostics Product Type

Table 9. Key Companies Time to Begin Mass Production of Respiratory Syncytial Virus (RSV) Diagnostics

Table 10. Global Respiratory Syncytial Virus (RSV) Diagnostics Companies Market Concentration Ratio (CR5 and HHI)

Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Respiratory Syncytial Virus (RSV) Diagnostics as of 2023)

Table 12. Mergers & Acquisitions, Expansion Plans

Table 13. Global Respiratory Syncytial Virus (RSV) Diagnostics Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 14. Global Respiratory Syncytial Virus (RSV) Diagnostics Sales Value by Type (2019-2024) & (US$ Million)

Table 15. Global Respiratory Syncytial Virus (RSV) Diagnostics Sales Value by Type (2025-2030) & (US$ Million)

Table 16. Global Respiratory Syncytial Virus (RSV) Diagnostics Sales Market Share in Value by Type (2019-2024) & (%)

Table 17. Global Respiratory Syncytial Virus (RSV) Diagnostics Sales Market Share in Value by Type (2025-2030) & (%)

Table 18. Global Respiratory Syncytial Virus (RSV) Diagnostics Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 19. Global Respiratory Syncytial Virus (RSV) Diagnostics Sales Value by Application (2019-2024) & (US$ Million)

Table 20. Global Respiratory Syncytial Virus (RSV) Diagnostics Sales Value by Application (2025-2030) & (US$ Million)

Table 21. Global Respiratory Syncytial Virus (RSV) Diagnostics Sales Market Share in Value by Application (2019-2024) & (%)

Table 22. Global Respiratory Syncytial Virus (RSV) Diagnostics Sales Market Share in Value by Application (2025-2030) & (%)

Table 23. Global Respiratory Syncytial Virus (RSV) Diagnostics Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 24. Global Respiratory Syncytial Virus (RSV) Diagnostics Sales Value by Region (2019-2024) & (US$ Million)

Table 25. Global Respiratory Syncytial Virus (RSV) Diagnostics Sales Value by Region (2025-2030) & (US$ Million)

Table 26. Global Respiratory Syncytial Virus (RSV) Diagnostics Sales Value by Region (2019-2024) & (%)

Table 27. Global Respiratory Syncytial Virus (RSV) Diagnostics Sales Value by Region (2025-2030) & (%)

Table 28. Key Countries/Regions Respiratory Syncytial Virus (RSV) Diagnostics Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 29. Key Countries/Regions Respiratory Syncytial Virus (RSV) Diagnostics Sales Value, (2019-2024) & (US$ Million)

Table 30. Key Countries/Regions Respiratory Syncytial Virus (RSV) Diagnostics Sales Value, (2025-2030) & (US$ Million)

Table 31. Roche Basic Information List

Table 32. Roche Description and Business Overview

Table 33. Roche Respiratory Syncytial Virus (RSV) Diagnostics Products, Services and Solutions

Table 34. Revenue (US$ Million) in Respiratory Syncytial Virus (RSV) Diagnostics Business of Roche (2019-2024)

Table 35. Roche Recent Developments

Table 36. AstraZeneca Basic Information List

Table 37. AstraZeneca Description and Business Overview

Table 38. AstraZeneca Respiratory Syncytial Virus (RSV) Diagnostics Products, Services and Solutions

Table 39. Revenue (US$ Million) in Respiratory Syncytial Virus (RSV) Diagnostics Business of AstraZeneca (2019-2024)

Table 40. AstraZeneca Recent Developments

Table 41. Merck Basic Information List

Table 42. Merck Description and Business Overview

Table 43. Merck Respiratory Syncytial Virus (RSV) Diagnostics Products, Services and Solutions

Table 44. Revenue (US$ Million) in Respiratory Syncytial Virus (RSV) Diagnostics Business of Merck (2019-2024)

Table 45. Merck Recent Developments

Table 46. AbbVie Basic Information List

Table 47. AbbVie Description and Business Overview

Table 48. AbbVie Respiratory Syncytial Virus (RSV) Diagnostics Products, Services and Solutions

Table 49. Revenue (US$ Million) in Respiratory Syncytial Virus (RSV) Diagnostics Business of AbbVie (2019-2024)

Table 50. AbbVie Recent Developments

Table 51. Bausch Health Basic Information List

Table 52. Bausch Health Description and Business Overview

Table 53. Bausch Health Respiratory Syncytial Virus (RSV) Diagnostics Products, Services and Solutions

Table 54. Revenue (US$ Million) in Respiratory Syncytial Virus (RSV) Diagnostics Business of Bausch Health (2019-2024)

Table 55. Bausch Health Recent Developments

Table 56. GlaxoSmithKline Basic Information List

Table 57. GlaxoSmithKline Description and Business Overview

Table 58. GlaxoSmithKline Respiratory Syncytial Virus (RSV) Diagnostics Products, Services and Solutions

Table 59. Revenue (US$ Million) in Respiratory Syncytial Virus (RSV) Diagnostics Business of GlaxoSmithKline (2019-2024)

Table 60. GlaxoSmithKline Recent Developments

Table 61. ReViral Basic Information List

Table 62. ReViral Description and Business Overview

Table 63. ReViral Respiratory Syncytial Virus (RSV) Diagnostics Products, Services and Solutions

Table 64. Revenue (US$ Million) in Respiratory Syncytial Virus (RSV) Diagnostics Business of ReViral (2019-2024)

Table 65. ReViral Recent Developments

Table 66. Gilead Sciences Basic Information List

Table 67. Gilead Sciences Description and Business Overview

Table 68. Gilead Sciences Respiratory Syncytial Virus (RSV) Diagnostics Products, Services and Solutions

Table 69. Revenue (US$ Million) in Respiratory Syncytial Virus (RSV) Diagnostics Business of Gilead Sciences (2019-2024)

Table 70. Gilead Sciences Recent Developments

Table 71. Teva Pharmaceutical Basic Information List

Table 72. Teva Pharmaceutical Description and Business Overview

Table 73. Teva Pharmaceutical Respiratory Syncytial Virus (RSV) Diagnostics Products, Services and Solutions

Table 74. Revenue (US$ Million) in Respiratory Syncytial Virus (RSV) Diagnostics Business of Teva Pharmaceutical (2019-2024)

Table 75. Teva Pharmaceutical Recent Developments

Table 76. Key Raw Materials Lists

Table 77. Raw Materials Key Suppliers Lists

Table 78. Respiratory Syncytial Virus (RSV) Diagnostics Downstream Customers

Table 79. Respiratory Syncytial Virus (RSV) Diagnostics Distributors List

Table 80. Research Programs/Design for This Report

Table 81. Key Data Information from Secondary Sources

Table 82. Key Data Information from Primary Sources

Table 83. Business Unit and Senior & Team Lead Analysts

List of Figures

Figure 1. Respiratory Syncytial Virus (RSV) Diagnostics Product Picture

Figure 2. Global Respiratory Syncytial Virus (RSV) Diagnostics Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Respiratory Syncytial Virus (RSV) Diagnostics Sales Value (2019-2030) & (US$ Million)

Figure 4. Respiratory Syncytial Virus (RSV) Diagnostics Report Years Considered

Figure 5. Global Respiratory Syncytial Virus (RSV) Diagnostics Players Revenue Ranking (2023) & (US$ Million)

Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Respiratory Syncytial Virus (RSV) Diagnostics Revenue in 2023

Figure 7. Respiratory Syncytial Virus (RSV) Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 8. Molecular Diagnosis Picture

Figure 9. Rapid Antigen Testing Picture

Figure 10. Other Picture

Figure 11. Global Respiratory Syncytial Virus (RSV) Diagnostics Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 12. Global Respiratory Syncytial Virus (RSV) Diagnostics Sales Value Market Share by Type, 2023 & 2030

Figure 13. Product Picture of Hospital

Figure 14. Product Picture of Clinic

Figure 15. Product Picture of Laborary

Figure 16. Product Picture of Other

Figure 17. Global Respiratory Syncytial Virus (RSV) Diagnostics Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 18. Global Respiratory Syncytial Virus (RSV) Diagnostics Sales Value Market Share by Application, 2023 & 2030

Figure 19. North America Respiratory Syncytial Virus (RSV) Diagnostics Sales Value (2019-2030) & (US$ Million)

Figure 20. North America Respiratory Syncytial Virus (RSV) Diagnostics Sales Value by Country (%), 2023 VS 2030

Figure 21. Europe Respiratory Syncytial Virus (RSV) Diagnostics Sales Value (2019-2030) & (US$ Million)

Figure 22. Europe Respiratory Syncytial Virus (RSV) Diagnostics Sales Value by Country (%), 2023 VS 2030

Figure 23. Asia Pacific Respiratory Syncytial Virus (RSV) Diagnostics Sales Value (2019-2030) & (US$ Million)

Figure 24. Asia Pacific Respiratory Syncytial Virus (RSV) Diagnostics Sales Value by Country (%), 2023 VS 2030

Figure 25. South America Respiratory Syncytial Virus (RSV) Diagnostics Sales Value (2019-2030) & (US$ Million)

Figure 26. South America Respiratory Syncytial Virus (RSV) Diagnostics Sales Value by Country (%), 2023 VS 2030

Figure 27. Middle East & Africa Respiratory Syncytial Virus (RSV) Diagnostics Sales Value (2019-2030) & (US$ Million)

Figure 28. Middle East & Africa Respiratory Syncytial Virus (RSV) Diagnostics Sales Value by Country (%), 2023 VS 2030

Figure 29. Key Countries/Regions Respiratory Syncytial Virus (RSV) Diagnostics Sales Value (%), (2019-2030)

Figure 30. United States Respiratory Syncytial Virus (RSV) Diagnostics Sales Value, (2019-2030) & (US$ Million)

Figure 31. United States Respiratory Syncytial Virus (RSV) Diagnostics Sales Value by Type (%), 2023 VS 2030

Figure 32. United States Respiratory Syncytial Virus (RSV) Diagnostics Sales Value by Application (%), 2023 VS 2030

Figure 33. Europe Respiratory Syncytial Virus (RSV) Diagnostics Sales Value, (2019-2030) & (US$ Million)

Figure 34. Europe Respiratory Syncytial Virus (RSV) Diagnostics Sales Value by Type (%), 2023 VS 2030

Figure 35. Europe Respiratory Syncytial Virus (RSV) Diagnostics Sales Value by Application (%), 2023 VS 2030

Figure 36. China Respiratory Syncytial Virus (RSV) Diagnostics Sales Value, (2019-2030) & (US$ Million)

Figure 37. China Respiratory Syncytial Virus (RSV) Diagnostics Sales Value by Type (%), 2023 VS 2030

Figure 38. China Respiratory Syncytial Virus (RSV) Diagnostics Sales Value by Application (%), 2023 VS 2030

Figure 39. Japan Respiratory Syncytial Virus (RSV) Diagnostics Sales Value, (2019-2030) & (US$ Million)

Figure 40. Japan Respiratory Syncytial Virus (RSV) Diagnostics Sales Value by Type (%), 2023 VS 2030

Figure 41. Japan Respiratory Syncytial Virus (RSV) Diagnostics Sales Value by Application (%), 2023 VS 2030

Figure 42. South Korea Respiratory Syncytial Virus (RSV) Diagnostics Sales Value, (2019-2030) & (US$ Million)

Figure 43. South Korea Respiratory Syncytial Virus (RSV) Diagnostics Sales Value by Type (%), 2023 VS 2030

Figure 44. South Korea Respiratory Syncytial Virus (RSV) Diagnostics Sales Value by Application (%), 2023 VS 2030

Figure 45. Southeast Asia Respiratory Syncytial Virus (RSV) Diagnostics Sales Value, (2019-2030) & (US$ Million)

Figure 46. Southeast Asia Respiratory Syncytial Virus (RSV) Diagnostics Sales Value by Type (%), 2023 VS 2030

Figure 47. Southeast Asia Respiratory Syncytial Virus (RSV) Diagnostics Sales Value by Application (%), 2023 VS 2030

Figure 48. India Respiratory Syncytial Virus (RSV) Diagnostics Sales Value, (2019-2030) & (US$ Million)

Figure 49. India Respiratory Syncytial Virus (RSV) Diagnostics Sales Value by Type (%), 2023 VS 2030

Figure 50. India Respiratory Syncytial Virus (RSV) Diagnostics Sales Value by Application (%), 2023 VS 2030

Figure 51. Respiratory Syncytial Virus (RSV) Diagnostics Industrial Chain

Figure 52. Respiratory Syncytial Virus (RSV) Diagnostics Manufacturing Cost Structure

Figure 53. Channels of Distribution (Direct Sales, and Distribution)

Figure 54. Bottom-up and Top-down Approaches for This Report

Figure 55. Data Triangulation

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Respiratory Syncytial Virus Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Respiratory Infection Diagnostic Market Research Report 2024

Respiratory Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Infectious Respiratory Disease Diagnostics Market Research Report 2025

Respiratory Syncytial Virus Diagnostic Testing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Respiratory Antivirals Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Virus Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Respiratory Disorders Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Respiratory Disorders Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Rapid Virus Diagnostic Test Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Respiratory Antiviral Treatment Market Research Report 2024

Global Respiratory Diagnostic Devices Market Research Report 2024

Virus Testing Diagnostic Kits Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Respiratory Syncytial Virus Fusion Protein Drug Market Research Report 2024

Respiratory Syncytial Virus RSV Testing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Anti Respiratory Syncytial Virus Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Infectious Disease Diagnostic Testing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Rapid Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Upper Respiratory Tract Disorder Diagnostics and Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions